FMS kinase inhibitors (Gilead Sciences)

N/A

Report date: 2025/06/20 20:01:04

NME

Base Information

Drug NameFMS kinase inhibitors (Gilead Sciences)

Drug Alias NameCSF-1R kinase inhibitors (Cytopia)CSF-1R kinase inhibitors (YM Biosciences)FMS kinase inhibitors (YM BioSciences)CSF-1R kinase inhibitors (Gilead Sciences)c-FMS inhibitors (Cytopia) +[7]

ClassificationSmall molecules

Mechanisms of ActionBone modulatorsAnticancer protein kinase inhibitorsMacrophage Colony Stimulating Factor 1 inhibitors

TargetsMacrophage Colony Stimulating Factor 1

Therapy Area/IndicationsInflammationAutoimmune DiseasesBone Diseases +[4]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia and New Zealand

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesYM BioSciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesYM BioSciences Inc Gilead Sciences Inc

Active IndicationsN/A

Inactive IndicationsInflammationAutoimmune DiseasesBone Diseases +[4]

Other Information

ATC CodeN/A